An examination of the relationships between common diseases and polymorphism may facilitate a better understanding of the clinical variability of illnesses and their genetic bases. In this paper, the relationship between blood group and erythrocyte phosphoglucomutase 1 (PGM1) enzyme phenotype and noninsulin-dependent diabetes mellitus (NIDDM) was investigated. The enzyme phenotypes of 205 diabetic individuals were determined using the agglutination method. The results were compared with data from 200 subjects in the control group. When the diabetic individuals and those in the control group were compared according to PGM1 phenotype, no statistically significant difference between the two was observed (p>0.05). However, in ABO and Rh phenotypes the difference was found to be significant (p

An examination of the relationships between common diseases and polymorphism may facilitate a better understanding of the clinical variability of illnesses and their genetic bases. In this paper, the relationship between blood group and erythrocyte phosphoglucomutase 1 (PGM1) enzyme phenotype and noninsulin-dependent diabetes mellitus (NIDDM) was investigated. The enzyme phenotypes of 205 diabetic individuals were determined using the agglutination method. The results were compared with data from 200 subjects in the control group. When the diabetic individuals and those in the control group were compared according to PGM1 phenotype, no statistically significant difference between the two was observed (p>0.05). However, in ABO and Rh phenotypes the difference was found to be significant (p